The rodent model described in the publication “Developing Magnetic Resonance Imaging Biomarkers of Neuroinflammation, Cognitive Impairment, and Survival Outcomes for Radiotherapy-Induced Brain Injury (RIBI) in a Preclinical Mouse Model” could play a critical role in enabling the better identification and characterization of noninvasive and clinically translatable longitudinal imaging biomarkers of RIBI. Furthermore, these noninvasive imaging biomarkers could aid in the evaluation of potential RIBI prophylactic and therapeutic agents, which are currently being developed.
As this research field continues to expand, preparation and distribution of these models will be a natural extension of existing research products and a beneficial tool for researchers in this space.
